Fundraising Fox
Spark Biomedical
Dallas, US · Founded 2023 · Delaware corporation · 29 employees on LinkedIn · 3 known investors
Find your way into Spark Biomedical
Sign up to see every warm intro you have to Spark Biomedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spark Biomedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.
Founders & leadership
DP
Daniel PowellPresident & Chief Executive OfficerDaniel Powell is a bioelectronic medicine executive with over 20 years of experience in engineering, program management, and commercialization across multiple industries. Since co-founding Spark Biomedical in 2018, he has led development of wearable neurostimulation devices for opioid withdrawal and women's health applications, and previously spent nearly two decades commercializing deep brain stimulation and vagus nerve stimulation technologies.
AC
Alejandro CovalinChief Technology OfficerAlejandro Covalin holds a PhD and brings over 20 years of experience in neuromodulation, wearable medical devices, and wireless medical systems, with expertise spanning R&D, clinical trials, regulatory strategy, and FDA-compliant design.
TC
Ted CostopoulosNamed on SEC filing
CR
Carl R. DeeleyNamed on SEC filing
Investors · 3
Funding
SEC filings, press & company announcements$31.2M disclosed across 2 rounds · 2023–2025
- $15MSeries AApr 2025 · 3 sources
WAVE Ventures (lead), Pathway to Cures
Source ↗
▶$16.2MraisedMay 2023 · 127 investors · Other Health CareRule 506(b)
▶$16.2MraisedMay 2023 · 127 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alejandro CovalinExecutive Officer, Director
- Navid KhodaparastExecutive Officer, Director
- Ted CostopoulosDirector
- Carl R. DeeleyDirector
- Daniel PowellExecutive Officer, Director
- Offering amount
- $21.8M
- Amount sold
- $16.2M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
SPARK NeuroSPARK Neuro develops brain health measurement technology for early detection and monitoring of cognitive conditions like dementia, targeting healthcare providers and individuals. The company aims to make brain health assessment a routine part of standard clinical care.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as Spark Biomedical.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. ArmyArmy | Phase IISTTR | 2023 | $1.1M |
| U.S. ArmyArmy | Phase ISTTR | 2022 | $172.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $217.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Spark Biomedical do?
- Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.
- Who are Spark Biomedical's investors?
- Spark Biomedical's investors include Aggie Angel Network, Pathway to Cures, Wave Ventures.
- How much funding has Spark Biomedical raised?
- Spark Biomedical has disclosed $31.2M raised across 2 rounds.
- Where is Spark Biomedical headquartered?
- Spark Biomedical is headquartered in Dallas, US.